Early pregnancy soluble E-selectin concentrations and risk of preeclampsia

Journal of Hypertension

Volumn 30, Issue 5, 2012, Pages 954-959

  Carty, David M ^a   Anderson, Lesley A ^a   Freeman, Dilys J ^a   Welsh, Paul I ^a   Brennand, Janet E ^b   Dominiczak, Anna F ^a   Delles, Christian ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

adhesion molecules; E selectin; inflammation; preeclampsia

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEALTH SERVICE; HUMAN; HYPERTENSION; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PERINATAL PERIOD; PREDICTION; PREECLAMPSIA; PRENATAL PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PUERPERIUM; RISK; RISK FACTOR; SAMPLE;

EID: 84859916522     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328352573b     Document Type: Article

References (33)

1. Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2008; 198:7-22.
2. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308:1592-1594. (Pubitemid 40807500)
3. Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003; 88:2348-2351. (Pubitemid 36549917)
4. Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV. First-trimester serum levels of soluble endoglin and soluble fmslike tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol 2008; 199:266.
5. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672-683. (Pubitemid 38364626)
6. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010; 122:478-487.
7. Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59:161-173. (Pubitemid 36945234)
8. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998; 40:102-111.
9. Chaiworapongsa T, Romero R, Yoshimatsu J, Espinoza J, Kim YM, Park K, et al. Soluble adhesion molecule profile in normal pregnancy and preeclampsia. J Matern Fetal Neonatal Med 2002; 12:19-27. (Pubitemid 34848424)
10. Kim SY, Ryu HM, Yang JH, Kim MY, Ahn HK, Lim HJ, et al. Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia. J Korean Med Sci 2004; 19:688-692.
11. Hanisch CG, Pfeiffer KA, Schlebusch H, Schmolling J. Adhesion molecules, activin and inhibin: candidates for the biochemical prediction of hypertensive diseases in pregnancy? Arch Gynecol Obstet 2004; 270:110-115. (Pubitemid 39208323)
12. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JC. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in preeclampsia: does this indicate the mechanism of leucocyte activation? Br J Obstet Gynaecol 1994; 101:485-487. (Pubitemid 24210147)
13. Papakonstantinou K, Economou E, Hasiakos D, Vitoratos N. Antepartum and postpartum maternal plasma levels of E-selectin in preeclampsia, gestational proteinuria and gestational hypertension. Eur J Obstet Gynecol Reprod Biol 2010; 153:112-113.
14. Chavarria ME, Lara-Gonzalez L, Garcia-Paleta Y, Vital-Reyes VS, Reyes A. Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia. Eur J Obstet Gynecol Reprod Biol 2008; 137:157-164. (Pubitemid 351423464)
15. Clausen T, Djurovic S, Brosstad FR, Berg K, Henriksen T. Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol 2000; 182:321-325. (Pubitemid 30127342)
16. Krauss T, Kuhn W, Lakoma C, Augustin HG. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 1997; 177:443-449. (Pubitemid 27385728)
17. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, et al. Short-and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44:708-714. (Pubitemid 39435242)
18. Bosio PM, Cannon S, McKenna PJ, O'Herlihy C, Conroy R, Brady H. Plasma P-selectin is elevated in the first trimester in women who subsequently develop preeclampsia. BJOG 2001; 108:709-715. (Pubitemid 32778277)
19. Carty DM, Siwy J, Brennand JE, Zurbig P, Mullen W, Franke J, et al. Urinary proteomics for prediction of preeclampsia. Hypertension 2011; 57:561-569.
20. Duckitt K, Harrington D. Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330:565.
21. Brown MA, Lindheimer MD, De Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:IX-XIV. (Pubitemid 32672922)
22. Roh MI, Lim SJ, Ahn JM, Lim JB, Kwon OW. Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection. Graefes Arch Clin Exp Ophthalmol 2010; 248:635-640.
23. Borzychowski AM, Sargent IL, Redman CW. Inflammation and preeclampsia. Semin Fetal Neonatal Med 2006; 11:309-316.
24. Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 2007; 49:90-95. (Pubitemid 46360346)
25. North RA, McCowan LM, Dekker GA, Poston L, Chan EH, Stewart AW, et al. Clinical risk prediction for preeclampsia in nulliparous women: development of model in international prospective cohort. BMJ 2011; 342:d1875.
26. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001; 357:53-56.
27. Wang Z, Liu Y, Liu J, Liu K, Lou Y, Wen J, et al. E-selectin gene polymorphisms are associated with essential hypertension: a case-control pilot study in a Chinese population. BMC Med Genet 2010; 11:127.
28. Abu-Amero KK, Al Boudari OM, Mohamed GH, Dzimiri N. E-selectin S128R polymorphism and severe coronary artery disease in Arabs. BMC Med Genet 2006; 7:52.
29. Roldan V, Marin F, Lip GY, Blann AD. Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature. Thromb Haemost 2003; 90:1007-1020. (Pubitemid 38004418)
30. Coata G, Pennacchi L, Bini V, Liotta L, Di Renzo GC. Soluble adhesion molecules: marker of preeclampsia and intrauterine growth restriction. J Matern Fetal Neonatal Med 2002; 12:28-34. (Pubitemid 34848425)
31. Matsubara K, Abe E, Ochi H, Kusanagi Y, Ito M. Changes in serum concentrations of tumor necrosis factor alpha and adhesion molecules in normal pregnant women and those with pregnancy-induced hypertension. J Obstet Gynaecol Res 2003; 29:422-426. (Pubitemid 38180683)
32. Guven M, Coskun A, Ertas I, Arat M, Zenciri B, Oksuz H. Association of maternal serum CRP, IL-6, TNF-a homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight. Hypertens Pregnancy 2009; 28:190-200.
33. Bretelle F, Sabatier F, Blann A, D'Ercole C, Boutiere B, Mutin M, et al. Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with preeclampsia. BJOG 2001; 108:1277-1282. (Pubitemid 34076740)